Indivior (INDV)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,714.00p
   
  • Change Today:
      9.00p
  • 52 Week High: 1,885.00
  • 52 Week Low: 1,135.00
  • Currency: UK Pounds
  • Shares Issued: 135.92m
  • Volume: 40,187
  • Market Cap: £2,329.61m
  • RiskGrade: 314

Geographical - by origin

  31-Dec-2331-Dec-2231-Dec-2131-Dec-2031-Dec-19
Revenue
Rest of Worldn/an/an/an/an/an/a182.0028%189.0024%
Unanalysed176.0016%164.0018%181.0023%n/an/an/an/a
United Kingdom5.00n/a6.001%7.001%9.001%7.001%
United States912.0083%731.0081%603.0076%456.0070%589.0075%
Total 1,093.00100% 901.00100% 791.00100% 647.00100% 785.00100% 
 
Profit Before Tax
Unanalysed1.00100%(95.00)100%190.00100%(173.00)100%180.00100%
Total 1.00100% (95.00)100% 190.00100% (173.00)100% 180.00100% 

Geographical - by origin (turnover)

Product breakdown (turnover)

Product breakdown

  31-Dec-2331-Dec-2231-Dec-2131-Dec-2031-Dec-19
Revenue
PERSERIS42.004%28.003%17.002%14.002%6.001%
SUBLOCADE630.0058%408.0045%244.0031%130.0020%72.009%
Sublingual / Othern/an/an/an/a530.0067%503.0078%707.0090%
Sublingual/Other 421 465421.0039%465.0052%n/an/an/an/an/an/a
Total 1,093.00100% 901.00100% 791.00100% 647.00100% 785.00100% 
 
Profit Before Tax
Unanalysed1.00n/a(95.00)n/a190.00n/a(173.00)n/a180.00n/a
Total 1.00n/a (95.00)n/a 190.00n/a (173.00)n/a 180.00n/a 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page